Losada-Grande, Eladio
Hawley, Samuel
Soldevila, Berta
Martinez-Laguna, Daniel
Nogues, Xavier
Diez-Perez, Adolfo
Puig-Domingo, Manel
Mauricio, DÃdac
Prieto-Alhambra, Daniel
Article History
Received: 2 September 2016
Accepted: 5 May 2017
First Online: 19 June 2017
Competing Interests
: D.P.A. declares that his department/research group has received unrestricted research grants from Amgen, Servier Laboratoires, and Bioiberica; X.N. has been paid by Amgen and Lilly for developing and delivering educational presentations; D.M. declares receipt of honoraria from Abbott, Astra Zeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Ferrer, Glaxo-Smithkline, Eli-Lilly, Medtronic, Merck Sharp & Dohme, Novartis, Novonordisk, and Sanofi for consulting and presentations. A.D.P. has been a speaker or advisory board member for Lilly, Amgen, G.S.K., and U.C.B. and owns stocks of Active Life Scientific; E.L.G., B.S., S.H., M.P.D. and D.M.L. have no conflicts of interest.